MAINTENANCE HORMONAL TREATMENT IMPROVES PROGRESSION FREE SURVIVAL AFTER A FIRST LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST CANCER

The present study was conducted in patients with metastatic breast cancer. Its aim was to identify the factors which influence progression -free survival (PFS) and overall survival (OS) after the first line of chemotherapy in patients with positive tumour hormone receptor status. The patients with e...

Descripción completa

Detalles Bibliográficos
Autores principales: Dufresne, Armelle, Pivot, Xavier, Tournigand, Christophe, Facchini, Thomas, Alweeg, Thierry, Chaigneau, Loic, De Gramont, Aimery
Formato: Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2008
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2367428/
https://www.ncbi.nlm.nih.gov/pubmed/18461187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2367428/
https://www.ncbi.nlm.nih.gov/pubmed/18461187

Ejemplares similares